Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control. 2007

Tommy Pattij, and Mieke C W Janssen, and Louk J M J Vanderschuren, and Anton N M Schoffelmeer, and Marcel M van Gaalen
Department of Anatomy and Neurosciences, Research Institute Neurosciences Vrije Universiteit, Center for Neurogenomics and Cognitive Research, VU medical center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands. t.pattij@vumc.nl

BACKGROUND Impaired inhibitory control over behavior is a key feature in various psychiatric disorders, and recent studies indicated an important role for dopamine D(1) and D(2) receptors and the nucleus accumbens (Acb) in this respect. OBJECTIVE The present experiments were designed to study the role of dopamine D(1) and D(2) receptors in the Acb in inhibitory response control. METHODS Rats were trained in a five-choice serial reaction time task and received bilateral infusions into the Acb core or shell of either SCH 23390 or eticlopride (representing selective dopamine D(1) and D(2) receptor antagonists, respectively). Subsequently, the effects of systemic amphetamine on inhibitory response control were examined. RESULTS Eticlopride into either the Acb core or shell did not affect premature responding, a measure for inhibitory response control, but increased reaction time and errors of omission. In contrast, SCH 23390 into both regions reduced premature responding, slightly improved attentional performance in the core and increased errors of omission in the shell. Amphetamine robustly increased premature responding which was dose-dependently blocked by eticlopride in the Acb core and attenuated by eticlopride in the shell. In addition, amphetamine slightly decreased accuracy and reaction time, and these effects were inhibited by eticlopride in both regions. SCH 23390 infusion into the Acb core or shell did not alter amphetamine's effects. CONCLUSIONS Our data provide evidence for the involvement of dopamine D(1) and D(2) receptors in the Acb core and shell in inhibitory response control and attentional performance.

UI MeSH Term Description Entries
D007175 Impulsive Behavior An act performed without delay, reflection, voluntary direction or obvious control in response to a stimulus. Impulsivity,Behavior, Impulsive,Behaviors, Impulsive,Impulsive Behaviors,Impulsivities
D007266 Inhibition, Psychological The interference with or prevention of a behavioral or verbal response even though the stimulus for that response is present; in psychoanalysis the unconscious restraining of an instinctual process. Inhibition (Psychology),Inhibition, Psychology,Psychological Inhibition,Inhibitions (Psychology),Inhibitions, Psychological,Inhibitions, Psychology,Psychological Inhibitions,Psychology Inhibition,Psychology Inhibitions
D008297 Male Males
D009714 Nucleus Accumbens Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA. Accumbens Nucleus,Nucleus Accumbens Septi,Accumbens Septi, Nucleus,Accumbens Septus, Nucleus,Accumbens, Nucleus,Nucleus Accumbens Septus,Nucleus, Accumbens,Septi, Nucleus Accumbens,Septus, Nucleus Accumbens
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D002755 Choice Behavior The act of making a selection among two or more alternatives, usually after a period of deliberation. Approach Behavior,Approach Behaviors,Behavior, Approach,Behavior, Choice,Behaviors, Approach,Behaviors, Choice,Choice Behaviors
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine
D000697 Central Nervous System Stimulants A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. Analeptic,Analeptic Agent,Analeptic Drug,Analeptics,CNS Stimulant,CNS Stimulants,Central Nervous System Stimulant,Central Stimulant,Analeptic Agents,Analeptic Drugs,Central Stimulants,Agent, Analeptic,Agents, Analeptic,Drug, Analeptic,Drugs, Analeptic,Stimulant, CNS,Stimulant, Central,Stimulants, CNS,Stimulants, Central
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Tommy Pattij, and Mieke C W Janssen, and Louk J M J Vanderschuren, and Anton N M Schoffelmeer, and Marcel M van Gaalen
July 2008, Learning & memory (Cold Spring Harbor, N.Y.),
Tommy Pattij, and Mieke C W Janssen, and Louk J M J Vanderschuren, and Anton N M Schoffelmeer, and Marcel M van Gaalen
February 2007, Neuroscience and behavioral physiology,
Tommy Pattij, and Mieke C W Janssen, and Louk J M J Vanderschuren, and Anton N M Schoffelmeer, and Marcel M van Gaalen
March 1991, Neuropharmacology,
Tommy Pattij, and Mieke C W Janssen, and Louk J M J Vanderschuren, and Anton N M Schoffelmeer, and Marcel M van Gaalen
July 1990, European journal of pharmacology,
Tommy Pattij, and Mieke C W Janssen, and Louk J M J Vanderschuren, and Anton N M Schoffelmeer, and Marcel M van Gaalen
August 2008, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Tommy Pattij, and Mieke C W Janssen, and Louk J M J Vanderschuren, and Anton N M Schoffelmeer, and Marcel M van Gaalen
January 1995, Brain research. Molecular brain research,
Tommy Pattij, and Mieke C W Janssen, and Louk J M J Vanderschuren, and Anton N M Schoffelmeer, and Marcel M van Gaalen
January 2010, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Tommy Pattij, and Mieke C W Janssen, and Louk J M J Vanderschuren, and Anton N M Schoffelmeer, and Marcel M van Gaalen
January 2009, Learning & memory (Cold Spring Harbor, N.Y.),
Tommy Pattij, and Mieke C W Janssen, and Louk J M J Vanderschuren, and Anton N M Schoffelmeer, and Marcel M van Gaalen
January 2020, Frontiers in neuroscience,
Tommy Pattij, and Mieke C W Janssen, and Louk J M J Vanderschuren, and Anton N M Schoffelmeer, and Marcel M van Gaalen
April 2015, The international journal of neuropsychopharmacology,
Copied contents to your clipboard!